Does the Current Evidence Base Support Lecanemab Continued Dosing for Early Alzheimer’s Disease?
Lecanemab Continued Dosing Symposium CTAD Presentation
Does the Current Evidence Base Support Lecanemab Continued Dosing for Early Alzheimer’s Disease?
